- Home
- CTRM vs CLNN Comparison
CTRM vs CLNN Comparison
Compare CTRM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- CLNN
- Stock Information
- Founded
- CTRM 2016
- CLNN 2012
- Country
- CTRM Cyprus
- CLNN United States
- Employees
- CTRM N/A
- CLNN N/A
- Industry
- CTRM Marine Transportation
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- CTRM Consumer Discretionary
- CLNN Health Care
- Exchange
- CTRM Nasdaq
- CLNN Nasdaq
- Market Cap
- CTRM 22.9M
- CLNN 23.1M
- IPO Year
- CTRM N/A
- CLNN N/A
- Fundamental
- Price
- CTRM $2.15
- CLNN $3.92
- Analyst Decision
- CTRM
- CLNN Strong Buy
- Analyst Count
- CTRM 0
- CLNN 5
- Target Price
- CTRM N/A
- CLNN $40.00
- AVG Volume (30 Days)
- CTRM 77.7K
- CLNN 140.0K
- Earning Date
- CTRM 08-07-2025
- CLNN 08-06-2025
- Dividend Yield
- CTRM N/A
- CLNN N/A
- EPS Growth
- CTRM N/A
- CLNN N/A
- EPS
- CTRM 0.38
- CLNN N/A
- Revenue
- CTRM $66,243,379.00
- CLNN $350,000.00
- Revenue This Year
- CTRM N/A
- CLNN N/A
- Revenue Next Year
- CTRM N/A
- CLNN $1,753.57
- P/E Ratio
- CTRM $5.56
- CLNN N/A
- Revenue Growth
- CTRM N/A
- CLNN N/A
- 52 Week Low
- CTRM $1.98
- CLNN $2.28
- 52 Week High
- CTRM $5.49
- CLNN $7.59
- Technical
- Relative Strength Index (RSI)
- CTRM 42.49
- CLNN 52.37
- Support Level
- CTRM $2.09
- CLNN $4.12
- Resistance Level
- CTRM $2.33
- CLNN $4.40
- Average True Range (ATR)
- CTRM 0.14
- CLNN 0.26
- MACD
- CTRM -0.03
- CLNN -0.06
- Stochastic Oscillator
- CTRM 12.77
- CLNN 7.89
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.